BioHarvest Sciences Inc. Common Stock (BHST) is a Agricultural Inputs company in the Basic Materials sector, currently trading at $4.27. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is BHST = $10 (+134.2% upside).
Valuation: BHST trades at a trailing Price-to-Earnings (P/E) of -7.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.11.
Financials: revenue is $35M, +88.8%/yr average growth. Net income is $11M (loss), growing at -0.3%/yr. Net profit margin is -32.3% (negative). Gross margin is 59.3% (+37.1 pp trend).
Balance sheet: total debt is $14M against $25M equity (Debt-to-Equity (D/E) ratio 0.55, moderate). Current ratio is 3.97 (strong liquidity). Debt-to-assets is 29.6%. Total assets: $48M.
Analyst outlook: 1 / 1 analysts rate BHST as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).
